Floatz logo

Polyethylene Glycol 3350

Acute Mountain Sickness

New York Presbyterian Brooklyn Methodist HospitalUNKNOWNN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Acute Mountain Sickness cohort.

Asset / SponsorPhaseRating
Fremanezumab
Insel Gruppe AG, University Hospital Bern
Phase 4BB
Lactulose
New York Presbyterian Brooklyn Methodist Hospital
N/AD

Same molecule, other indications

Polyethylene Glycol 3350 is also rated in:

constipation disorderActive
BB
Indicative · Phase 4
65 / 100
View asset →
kidney cancerActive
B
Indicative · Phase 4
59 / 100
View asset →
colon carcinomaDormant
B
Indicative · Phase 3
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →